tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
ANNX
Annexon Biosciences
RESEARCH TOOLSreports
Want to see ANNX full AI Analyst Report?

Annexon Biosciences (ANNX) Financial Statements

1,401 Followers

Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently $1.02B. The company's EPS TTM is $-0.28; its P/E ratio is -4.03; Annexon Biosciences is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -3.69M$ -3.45M$ 0.00$ 0.00$ 0.00
Operating Income$ -216.41M$ -154.07M$ -143.72M$ -145.60M$ -130.71M
EBITDA$ -213.76M$ -134.75M$ -141.57M$ -143.45M$ -128.57M
Net Income$ -206.69M$ -138.20M$ -134.24M$ -141.95M$ -130.32M
Balance Sheet
Cash & Short-Term Investments$ 238.34M$ 312.02M$ 259.72M$ 242.66M$ 242.72M
Total Assets$ 277.57M$ 350.07M$ 297.67M$ 285.10M$ 287.04M
Total Debt$ 26.20M$ 28.97M$ 31.36M$ 32.86M$ 34.59M
Net Debt$ -135.85M$ -20.53M$ -193.75M$ -107.16M$ -40.25M
Total Liabilities$ 65.92M$ 56.97M$ 47.12M$ 53.90M$ 55.13M
Stockholders' Equity$ 211.65M$ 293.11M$ 250.56M$ 231.19M$ 231.91M
Cash Flow
Free Cash Flow$ -186.49M$ -118.02M$ -121.33M$ -122.83M$ -107.76M
Operating Cash Flow$ -186.36M$ -118.01M$ -121.14M$ -116.31M$ -106.11M
Investing Cash Flow$ 190.05M$ -218.80M$ 70.70M$ 58.44M$ -88.24M
Financing Cash Flow$ 108.86M$ 161.21M$ 135.52M$ 122.91M$ 1.79M
Currency in USD

Annexon Biosciences Earnings and Revenue History

Income Statement >

Annexon Biosciences Debt to Assets

Balance Sheet >

Annexon Biosciences Cash Flow

Cash Flow >

Annexon Biosciences Forecast EPS vs Actual EPS

Earnings >